Rudolf Arnold

10.0k total citations · 2 hit papers
112 papers, 7.2k citations indexed

About

Rudolf Arnold is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Rudolf Arnold has authored 112 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 47 papers in Surgery and 40 papers in Oncology. Recurrent topics in Rudolf Arnold's work include Neuroendocrine Tumor Research Advances (54 papers), Lung Cancer Research Studies (25 papers) and Neuroblastoma Research and Treatments (23 papers). Rudolf Arnold is often cited by papers focused on Neuroendocrine Tumor Research Advances (54 papers), Lung Cancer Research Studies (25 papers) and Neuroblastoma Research and Treatments (23 papers). Rudolf Arnold collaborates with scholars based in Germany, United States and Switzerland. Rudolf Arnold's co-authors include Burkhard Göke, Thomas M. Gress, Anja Rinke, Carmen Schade‐Brittinger, Hans‐Helge Müller, Behnaz Aminossadati, Christian Arnold, Ulrich‐Frank Pape, Klaus‐Jochen Klose and Peter Barth and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Rudolf Arnold

112 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

2009 1.8k citations Anja Rinke, Hans‐Helge Müller et al. Journal of Clinical Oncology profile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

2017 303 citations Anders Sundin, Rudolf Arnold et al. Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rudolf Arnold Germany	41	4.6k	4.0k	3.1k	1.6k	1.2k	112	7.2k
Ulrich Knigge Denmark	50	5.7k 1.2×	5.2k 1.3×	3.8k 1.2×	1.0k 0.6×	490 0.4×	228	9.3k
Håkan Ahlman Sweden	37	2.1k 0.5×	1.7k 0.4×	1.5k 0.5×	1.1k 0.7×	841 0.7×	113	4.3k
Beata Kos‐Kudła Poland	34	3.0k 0.7×	2.6k 0.7×	1.7k 0.5×	428 0.3×	612 0.5×	243	4.9k
F. Stadil Denmark	32	1.2k 0.3×	610 0.2×	245 0.1×	2.2k 1.4×	1.2k 1.0×	124	4.6k
Ettore C. degli Uberti Italy	46	1.5k 0.3×	826 0.2×	898 0.3×	1.6k 1.0×	3.9k 3.2×	224	7.0k
Kaoru Abe Japan	38	688 0.1×	1.1k 0.3×	279 0.1×	601 0.4×	764 0.6×	191	4.4k
James E. McGuigan United States	37	1.4k 0.3×	496 0.1×	332 0.1×	2.2k 1.4×	447 0.4×	164	4.6k
Joseph S. Dillon United States	29	748 0.2×	666 0.2×	457 0.1×	656 0.4×	1.1k 0.8×	75	2.7k
Lídia Sabater Spain	45	813 0.2×	518 0.1×	4.9k 1.6×	1.0k 0.6×	579 0.5×	124	7.0k
Masanobu Yamada Japan	31	970 0.2×	465 0.1×	212 0.1×	624 0.4×	632 0.5×	190	3.9k

Countries citing papers authored by Rudolf Arnold

Since Specialization

Citations

This map shows the geographic impact of Rudolf Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Arnold more than expected).

Fields of papers citing papers by Rudolf Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Arnold. The network helps show where Rudolf Arnold may publish in the future.

Co-authorship network of co-authors of Rudolf Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Arnold. A scholar is included among the top collaborators of Rudolf Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Arnold. Rudolf Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borbath, Ivan, Ulrich‐Frank Pape, Pierre H. Deprez, et al.. (2022). ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. Journal of Neuroendocrinology. 34(3). e13105–e13105. 13 indexed citations

Sundin, Anders, Rudolf Arnold, Éric Baudin, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. Neuroendocrinology. 105(3). 212–244. 303 indexed citations breakdown →

Kvols, Larry K., Kjell E. Öberg, Thomas M. O’Dorisio, et al.. (2012). Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study. Endocrine Related Cancer. 19(5). 657–666. 152 indexed citations

Rinke, Anja, Hans‐Helge Müller, Carmen Schade‐Brittinger, et al.. (2009). Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group. Journal of Clinical Oncology. 27(28). 4656–4663. 1773 indexed citations breakdown →

Schipper, Meike L., Alexander Weber, Martin Béhé, et al.. (2003). Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.. PubMed. 63(6). 1333–8. 37 indexed citations

Anlauf, Martin, R. Eissele, Martin Schäfer, et al.. (2003). Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors. Journal of Histochemistry & Cytochemistry. 51(8). 1027–1040. 99 indexed citations

Feurle, Gerhard E., Martin Anlauf, Gerd Hamscher, et al.. (2002). Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology. 123(5). 1616–1626. 17 indexed citations

Trümper, K, et al.. (2000). Integrative Mitogenic Role of Protein Kinase B/Akt in β‐Cells. Annals of the New York Academy of Sciences. 921(1). 242–250. 55 indexed citations

Eissele, R., Martin Anlauf, Martin Schäfer, et al.. (1999). Expression of Vesicular Monoamine Transporters in Endocrine Hyperplasia and Endocrine Tumors of the Oxyntic Stomach. Digestion. 60(5). 428–439. 47 indexed citations

10.

Klose, Klaus J., et al.. (1999). Combination Therapy With Octreotide and α-Interferon:. The American Journal of Gastroenterology. 94(5). 1381–1387. 16 indexed citations

11.

Mönnikes, Hubert, et al.. (1996). Microinfusion of corticotropin-releasing factor into the locus coeruleus/subcoeruleus nuclei inhibits gastric acid secretion via spinal pathways in the rat. Brain Research. 728(2). 157–165. 14 indexed citations

12.

Eissele, R., et al.. (1994). Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study. Cell and Tissue Research. 276(3). 571–580. 9 indexed citations

13.

Katschinski, Martin, Jörg Schirra, Rudolf Arnold, et al.. (1994). Effect of cholecystokinin-A-receptor blockade on oesophageal motility. European Journal of Gastroenterology & Hepatology. 6(11). 983–990. 6 indexed citations

14.

Koop, H., et al.. (1993). Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man. Digestive Diseases and Sciences. 38(2). 295–302. 12 indexed citations

15.

Trautmann, Michael, et al.. (1992). Stimulation of Insulin Release Is Uncoupled from Insulin Biosynthesis in Tumoral RINmSF Cells. Pancreas. 7(2). 245–250. 2 indexed citations

16.

Fehmann, Hans-Christoph, et al.. (1991). Priming effect of glucagon-like peptide-1 (7–36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1091(3). 356–363. 25 indexed citations

17.

Bozkurt, T, et al.. (1988). Plasma CCK levels in patients with pancreatic insufficiency. Digestive Diseases and Sciences. 33(3). 276–281. 28 indexed citations

18.

Koop, H., et al.. (1986). Effect of starvation on endocrine cells in the rat stomach. Regulatory Peptides. 14(1). 33–39. 12 indexed citations

19.

Mundlos, Stefan, et al.. (1986). Exocrine Pancreatic Function in Oleic Acid-Induced Pancreatic Insufficiency in Rats. Pancreas. 1(1). 29–36. 26 indexed citations

20.

Koop, H., et al.. (1982). Effect of Food Deprivation on Rat Gastric Somatostatin and Gastrin Release. Gastroenterology. 82(5). 871–876. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact